Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations - Yang, J C; Hirsh, V; Schuler, M (J Clin Oncol, 2013)
et al.